Details

Autor(en) / Beteiligte

• Gouveia, Miguel
• Borges, Margarida
• Costa, João
• Lourenço, Francisco
• Fiorentino, Francesca
• Rodrigues, António Teixeira
• Teixeira, Inês
• Guerreiro, José Pedro
• Caetano, Patrícia
• Carneiro, António Vaz

Titel

Measuring the value of solidarity: The abem financial assistance program for out-of-pocket payments on pharmacy medicines in Portugal

Ist Teil von

• Journal of health services research & policy, 2024-01, Vol.29 (1), p.4-11

Ort / Verlag

England: Sage Publications Ltd

Erscheinungsjahr

2024

Link zum Volltext

Quelle

Applied Social Sciences Index & Abstracts (ASSIA)

Beschreibungen/Notizen

• Out-of-pocket payments for prescribed medicines are still comparatively high in Portugal. The program was launched in Portugal in May 2016 to aid vulnerable groups by completely covering out-of-pocket costs of prescribed medicines in community pharmacies. This study assesses the impact of the program on poverty and catastrophic health expenditures. A longitudinal study was carried out with the analysis of several program databases (from the beginning of the program in May 2016 to September 2018) covering the cohorts of beneficiaries, daily data on medicines dispensed, social referencing entities, and solidarity pharmacies. The study provides estimates of standard poverty measures (intensity and severity) as well as the incidence of catastrophic health expenditures. More than 6000 beneficiaries were supported (56.8% female, 34.7% aged 65 or over), encompassing 127,510 medicines (mainly nervous system and cardiovascular system) with an average 26.9% co-payment (payments totalling €1.5 million). The program achieved substantial reductions in poverty (3.4% in intensity, 5.6% in severity), and eliminated cases with catastrophic health expenditures in medicines that would have affected 7.5% of the beneficiaries. Findings confirm a continuous increase in the number of beneficiaries, enabling access to medicines especially for the vulnerable elderly, and a sizable impact on eliminating out-of-pocket payments for medicines in the target population.